CASE STUDIES

How the Head of Global Market Access for an oral oncolytic was able to increase revenue potential by thinking outside the U.S.

How a strategic evaluation of an Alternate Site of Care (ASOC) Network helped a manufacturer identify the ASOCs that best aligned with its goals

How a thorough assessment of a manufacturer's patient services department helped optimize a Hybrid HUB for future success.

How a U.S. biotech company established a global supply chain for a cell therapy with complicated and unique characteristics.

How a young biotech company with only a handful of employees was fully contracted and on schedule to implement in advance of launch.

How a mid-sized manufacturer's commercial operations team increased efficiency and drove future scalability with a comprehensive third-party assessment.

How a growing manufacturer identified $2.7M in savings with a thorough analysis of their existing Distribution Service Agreements.

How one manufacturer is now leveraging more accurate, meaningful, and actionable data to make strategic decisions.

How a young biotech company successfully integrated data across seven external vendors

How a large manufacturer accelerated time to therapy with a full suite of digitalized services.

How a large manufacturer was able to leverage benchmark fee ranges to better negotiate distribution agreements.

How a pharmaceutical company determined the best distribution strategy for a challenging oncology product.

How a small pharmaceutical manufacturer realized significant savings following a review of distribution partner contracts.

How a manufacturer was able to design and implement an enhanced platform for Field Reimbursement Specialists to reduce case barriers and improve medication fulfillment rates.

How an US-based cell therapy company overcame a tight timeline to gain insights from key stakeholders across 5 European markets.

How a pharmaceutical company revamped an old, inefficient HUB model to save 1/4 of their annual budget and increase sales by 1/3.

How a manufacturer successfully prepared for a hybrid HUB launch by temporarily extending their team's expertise.

How a thorough assessment of a hospital system specialty pharmacy helped optimize its value proposition and capabilities for future success.

How one manufacturer decreased time to fill by 2 months and boosted incremental revenue by $15M.

How a manufacturer was able to align multiple stakeholder needs to select the best Limited Distribution Specialty Pharmacy for their rare disease product

How a manufacturer was able to rescue 25% of pending referrals in less than 2 months, amounting to an initial $11M revenue boost

How a new manufacturer successfully relaunched a stagnant product line with limited trade and distribution staff and experience.

How a biotech company was able to quickly understand the retinal landscape to build a commercial distribution strategy for their first launch.

How a biotech company was able to identify and address potential future commercial operational complexities early in clinical development.

How a manufacturer was able to identify and correct significant site of care issues ahead of launch.

How a small biotech successfully managed escalations around launch without adding staff.

How a manufacturer was able to systematically assess and address Patient Services Program performance issues

How a large, global manufacturer successfully managed a patient support launch strategy in a crowded specialty market on time and under budget.

How an established patient support program was able to identify and overcome design barriers to stimulate access.

How a large manufacturer was able to identify additional access drivers for a PSP model design ahead of launch, while securing essential internal stakeholder support.

How one manufacturer is optimally positioned for distribution success ahead of its Prescription Digital Therapeutic (PDT) launch

How implementing a Quality Management System helped a Brand team improve benefit verification accuracy by 4.8% in 2 months.

How one manufacturer implemented several patient support initiatives over a 6-month period by bringing on temporary skilled staffing support.

How a new oncology therapy used a well-designed SP network to overcome AE concerns and exceed sales expectations.

How one manufacturer leveraged smart contracting to find innovation and flexibility alongside efficiencies and overall savings.

How a manufacturer selected a 3PL partner best suited to the unique needs of their product and immediately began preparing for launch.

How an emerging manufacturer was able to launch their first drug on-time with relatively few issues, given a short runway and resource constraints.

How a mid-sized manufacturer met the complex needs of their pediatric product's stakeholders by placing support services at the SP, instead of the HUB

How a large manufacturer successfully transitioned an internal, 5-product HUB to a third-party vendor on schedule.

How a cell therapy manufacturer was able to avoid COVID-19 disruptions to their distribution model.